Effect of Treatment With Systane Ultra in Symptomatology and Visual Task Efficiency in Digital Device Users
NCT ID: NCT06505174
Last Updated: 2024-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2023-01-10
2023-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
NCT00938951
Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline
NCT01252121
Evaluation of Systane Complete for the Treatment of Contact Lens Discomfort
NCT03682809
Efficacy of Systane Balance to Stabilize the Tear Film in Dry Eye Subjects
NCT01086774
Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use
NCT00347984
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Blink rate and number of eye fixations (collected with eye-tracker) in six simple computer tasks and out-loud reading speed were determined before and after performing all tasks on the computer. Tear film stability and ocular parameters were also measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Use of hydroxypropyl Guar-based artificial tears four times per day
Use of hydroxypropyl Guar-based artificial tears four times per day
Hydroxypropyl Guar-based artificial tears four times per day
Use of hydroxypropyl Guar-based artificial tears four times per day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hydroxypropyl Guar-based artificial tears four times per day
Use of hydroxypropyl Guar-based artificial tears four times per day
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Eye discomfort related to dryness (OSDI score ranged from 13 to 24)
* Symptomatic digital device users (CVSS17 score ranged from 29 to 42 points - stages 3 and 4)
* Use of computer continuously for at least 4 hours per day (work week)
* Good best-corrected visual acuity (Visual acuity LogMar ≤ 0.00 for distance, intermediate (60cm) and near (40cm))
Exclusion Criteria
* Topical administration of any drugs that can alter the ocular surface.
* Use of contact lenses
* Use of artificial tears or lubricants at least 7 days before inclusion in the study (recruitment visit).
* Any other ocular pathology or binocular conditions which may cause discomfort (e.g. heterophoric, accommodative, and eye movement disorders)
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Valladolid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raul Martin Herranz
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IOBA Eye Institute
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UVaGiO-PI222911
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.